Acute Coronary Syndrome Global Clinical Trials Review -





Published: November 2013 | Pages: 143 | Format: PDF

 Summary 

 GlobalData's clinical trial report, "Acute Coronary Syndrome Global Clinical Trials Review, H2, 2013" provides data on the Acute Coronary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Coronary Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Coronary Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. 

 Scope 

 - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations  

 - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type 

 - Listings of discontinued trials (suspended, withdrawn and terminated) 

 Reasons to buy 

 - Understand the dynamics of a particular indication in a condensed manner 

 - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more 

 - Obtain discontinued trial listing for trials across the globe 

 - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies 

 Table of Contents 

 Table of Contents 2 

 List of Tables 4 

 List of Figures 5 

 Introduction 6 

 Acute Coronary Syndrome 6 

 Report Guidance 6 

 Clinical Trials by Region 7 

 Clinical Trials by Country 8 

 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 

 Top Five Countries Contributing to Clinical Trials in Europe 11 

 Top Countries Contributing to Clinical Trials in North America 12 

 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 

 Top Five Countries Contributing to Clinical Trials in Central and South America 14 

 Clinical Trials by BRIC Nations 15 

 Clinical Trials by G7 Nations 16 

 Clinical Trials in G7 Nations by Trial Status 17 

 Clinical Trials by E7 Nations 18 

 Clinical Trials in E7 Nations by Trial Status 19 

 Clinical Trials by Phase 20 

 In Progress Trials by Phase 21 

 Clinical Trials by Trial Status 22 

 Unaccomplished Trials of Acute Coronary Syndrome 23 

 Subjects Recruited Over a Period of Time 27 

 Prominent Sponsors 28 

 Top Companies Participating in Acute Coronary Syndrome Therapeutics Clinical Trials 30 

 Prominent Drug Comparison 32 

 Clinical Trial Profiles 33 

 Clinical Trial Overview of Top Companies 33 

 AstraZeneca PLC 33 

 Clinical Trial Overview of AstraZeneca PLC 33 

 Eli Lilly and Company 36 

 Clinical Trial Overview of Eli Lilly and Company 36 

 Sanofi 38 

 Clinical Trial Overview of Sanofi 38 

 Daiichi Sankyo Company, Limited 40 

 Clinical Trial Overview of Daiichi Sankyo Company, Limited 40 

 Pfizer Inc. 42 

 Clinical Trial Overview of Pfizer Inc. 42 

 GlaxoSmithKline plc 43 

 Clinical Trial Overview of GlaxoSmithKline plc 43 

 The Medicines Company 44 

 Clinical Trial Overview of The Medicines Company 44 

 Bristol-Myers Squibb Company 45 

 Clinical Trial Overview of Bristol-Myers Squibb Company 45 

 Merck & Co., Inc. 46 

 Clinical Trial Overview of Merck & Co., Inc. 46 

 Clinical Trial Overview of Top Institutes / Government 47 

 University of Patras 47 

 Clinical Trial Overview of University of Patras 47 

 Massachusetts General Hospital 48 

 Clinical Trial Overview of Massachusetts General Hospital 48 

 Shenyang Northern Hospital 49 

 Clinical Trial Overview of Shenyang Northern Hospital 49 

 French Cardiology Society 50 

 Clinical Trial Overview of French Cardiology Society 50 

 University of Zurich 51 

 Clinical Trial Overview of University of Zurich 51 

 Royal Brompton & Harefield NHS Foundation Trust 52 

 Clinical Trial Overview of Royal Brompton & Harefield NHS Foundation Trust 52 

 Juntendo University 53 

 Clinical Trial Overview of Juntendo University 53 

 MedStar Health Research Institute 54 

 Clinical Trial Overview of MedStar Health Research Institute 54 

 Yokohama City University Medical Center 55 

 Clinical Trial Overview of Yokohama City University Medical Center 55 

 National Heart, Lung, and Blood Institute 56 

 Clinical Trial Overview of National Heart, Lung, and Blood Institute 56 

 Five Key Clinical Profiles 57 

 Appendix 140 

 Abbreviations 140 

 Definitions 140 

 Research Methodology 141 

 Secondary Research 141 

 About GlobalData 142 

 Contact Us 142 

 Disclaimer 142 

 Source 143 

  

 List of Tables 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11 

 Acute Coronary Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2013* 12 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14 

 Acute Coronary Syndrome Therapeutics Clinical Trials, BRIC Countries, 2013* 15 

 Acute Coronary Syndrome Therapeutics Clinical Trials, G7 Countries, 2013* 16 

 Acute Coronary Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17 

 Acute Coronary Syndrome Therapeutics Clinical Trials, E7 Countries, 2013* 18 

 Acute Coronary Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22 

 Acute Coronary Syndrome Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23 

 Acute Coronary Syndrome Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23 

 Acute Coronary Syndrome Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 33 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 36 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 38 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 40 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 42 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 43 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2013* 44 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 45 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 46 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Patras, 2013* 47 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 48 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenyang Northern Hospital, 2013* 49 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2013* 50 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 51 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Brompton & Harefield NHS Foundation Trust, 2013* 52 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University, 2013* 53 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by MedStar Health Research Institute, 2013* 54 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University Medical Center, 2013* 55 

 Acute Coronary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 56 

 

 List of Figures 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11 

 Acute Coronary Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14 

 Acute Coronary Syndrome Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15 

 Acute Coronary Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2013* 16 

 Acute Coronary Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17 

 Acute Coronary Syndrome Therapeutics Clinical Trials, E7 Countries (%), 2013* 18 

 Acute Coronary Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21 

 Acute Coronary Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30 

 Acute Coronary Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32 

 GlobalData Methodology 141